Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?
Alaide Chieffo and Antonio Colombo*
Correspondence *EMO Centro Cuore Columbus, via M Buonarroti 48, 20145 Milan, Italy
Email colombo@emocolumbus.it
Revascularization is currently recommended for patients with unprotected left main coronary artery disease. In this review, Chieffo and Colombo discuss the safety and effectiveness of percutaneous interventions involving drug-eluting stents as an alternative approach for treating this disease.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
